Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News TCT 2024

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

Yael L. Maxwell

October 30, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Role of Advanced Imaging Guidance by AI-Based Device Intelligence

Presenter: Susheel Kodali

October 29, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

TRISCEND II: Understanding the Study Design and Interpreting the Results

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

Clinical Results with the DurAVR THV System

Presenter: Susheel K. Kodali

June 05, 2024

Podcast TCTMD Talking Points

The TRISCEND II Trial

May 22, 2024

Presentation THT 2024

Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel

Presenter: Susheel K. Kodali

March 04, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

Video

» Interview

Beyond the Data: TRISCEND II

October 30, 2024

Video

» Interview

New Tricuspid Therapies: From Clinical Trial to Clinical Practice

June 26, 2024

Advertisement

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

How to Manage After TTVI?

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Role of Advanced Imaging Guidance by AI-Based Device Intelligence

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)

Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality?

TRISCEND II: Understanding the Study Design and Interpreting the Results

Clinical Results with the DurAVR THV System

The TRISCEND II Trial

Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

Beyond the Data: TRISCEND II

New Tricuspid Therapies: From Clinical Trial to Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content